JERUSALEM, October 11, 2016 /PRNewswire/ --
Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to the Company's...
↧